This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mark's Most Recent Article

The Run-Up Trade: Biodel's Insulin Trial Results

05/30/13 - 08:00 AM EDT

Biodel shares should move higher ahead of insulin trial results in the third quarter.

read more >

Other Articles by Mark

Free Reports

Rockwell Medical Run-Up Trade Follows Financing

05/21/13 - 08:00 AM EDT

One trader believes Rockwell shares will rise into clinical trial results expected in July.

read more >
Synta Is Run-Up to ASCO Lung Cancer Data

05/14/13 - 10:16 AM EDT

The market overreacted to the resignation of Synta's R&D chief.

read more >
Expecting Ziopharm Shares To Run Into Phase III Data At Month's End

03/04/13 - 07:00 AM EST

Ziopharm is an example of a stock with clinical trial results that can be traded realtively safely.

read more >
Run-Up Trade Into Dynavax's FDA Approval Decision

02/13/13 - 07:00 AM EST

Three factors that will cause Dynavax shares to gain as get closer to the approval of its Hep B vaccine.

read more >
Titan Pharma: Run-Up Trade Into March FDA Panel

01/31/13 - 06:03 AM EST

I expect traders will get an opportunity to profit from increased focus on Titan through March.

read more >
A.P. Pharma Run-Up Trade Into FDA Approval Decision

01/22/13 - 08:32 AM EST

Look at A.P. Pharma as a trade, not as a long-term investment, says trader Mark Messier.

read more >
Shorting Alexza Pharma On FDA's Adasuve Approval

12/19/12 - 07:00 AM EST

Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.

read more >
Anacor Pharma: Run-Up Trade Into January Trial Data

12/11/12 - 08:29 AM EST

Anacor will be releasing phase III results for a toenail fungus drug in January.

read more >
Hyperion Shares Poised to Run Up Ahead of FDA Decision

12/05/12 - 08:00 AM EST

FDA expected to issue approval decision on orphan drug Ravicti on Jan. 23.

read more >
Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs